Mankind Pharma Limited (MANKIND.BO)
INR 2343.55
(-1.47%)
INR 2343.55
(-1.47%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 23.87 Billion INR | 15.52% |
| 2022 | 20.66 Billion INR | -27.01% |
| 2021 | 28.31 Billion INR | 87.54% |
| 2020 | 15.09 Billion INR | 7.71% |
| 2019 | 14.01 Billion INR | 23.96% |
| 2018 | 11.3 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -95.75 Billion INR | -501.09% |
| 2023 Q2 | 24.64 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 23.87 Billion INR | 15.52% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 23.87 Billion INR | 0.0% |
| 2022 Q4 | 20.66 Billion INR | 6.08% |
| 2022 FY | 20.66 Billion INR | -27.01% |
| 2022 Q3 | 19.48 Billion INR | 0.0% |
| 2021 Q4 | 28.31 Billion INR | 0.0% |
| 2021 FY | 28.31 Billion INR | 87.54% |
| 2020 FY | 15.09 Billion INR | 7.71% |
| 2019 FY | 14.01 Billion INR | 23.96% |
| 2018 FY | 11.3 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | -46.706% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 84.314% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | -360.821% |
| Granules India Limited | 22.95 Billion INR | -4.009% |
| Indoco Remedies Limited | 10.34 Billion INR | -130.845% |
| Achyut Healthcare Limited | 2.01 Million INR | -1185924.143% |
| Ajanta Pharma Limited | 10.71 Billion INR | -122.913% |
| Alkem Laboratories Limited | 48.6 Billion INR | 50.88% |
| Alpa Laboratories Limited | 307.12 Million INR | -7673.675% |
| Brooks Laboratories Limited | 248.6 Million INR | -9503.608% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | -552.116% |
| Bajaj HealthCare Limited | 4.86 Billion INR | -390.474% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | -1032.117% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 77.681% |
| Eris Lifesciences Limited | 38.26 Billion INR | 37.612% |
| FDC Limited | 3.7 Billion INR | -543.659% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 63.332% |
| Gufic Biosciences Limited | 5.59 Billion INR | -326.348% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | -942.807% |
| Ipca Laboratories Limited | 33.74 Billion INR | 29.245% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -7945.109% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | -702.803% |
| Lasa Supergenerics Limited | 541.92 Million INR | -4305.53% |
| Laurus Labs Limited | 42.71 Billion INR | 44.107% |
| Lupin Limited | 96.23 Billion INR | 75.192% |
| Medicamen Biotech Limited | 940.36 Million INR | -2438.867% |
| Medico Remedies Limited | 438.24 Million INR | -5347.802% |
| Megasoft Limited | 1.85 Billion INR | -1188.334% |
| NATCO Pharma Limited | 10.53 Billion INR | -126.687% |
| Piramal Pharma Limited | 74 Billion INR | 67.739% |
| RPG Life Sciences Limited | 1.38 Billion INR | -1629.798% |
| Sigachi Industries Limited | 2.53 Billion INR | -843.191% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 86.994% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | -1073.647% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -1948.956% |
| Unichem Laboratories Limited | 8.06 Billion INR | -195.872% |
| Wanbury Limited | 3.15 Billion INR | -656.601% |
| Windlas Biotech Limited | 1.76 Billion INR | -1254.437% |
| ZIM Laboratories Limited | 2.08 Billion INR | -1047.4% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 66.745% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | -513.287% |
| Divi's Laboratories Limited | 18.99 Billion INR | -25.722% |
| Hester Biosciences Limited | 3.59 Billion INR | -564.159% |
| Procter & Gamble Health Limited | 2.56 Billion INR | -832.167% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -2945.922% |
| Bal Pharma Limited | 2.51 Billion INR | -850.699% |
| Strides Pharma Science Limited | 37.68 Billion INR | 36.639% |
| Venus Remedies Limited | 1.39 Billion INR | -1614.149% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | -189.365% |
| Nectar Lifesciences Limited | 11.21 Billion INR | -112.823% |
| Shilpa Medicare Limited | 12.93 Billion INR | -84.61% |
| Aarti Drugs Limited | 11.5 Billion INR | -107.534% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | -277.232% |
| Suven Life Sciences Limited | 148.62 Million INR | -15964.127% |
| Ind-Swift Limited | 13.45 Billion INR | -77.468% |
| Valiant Laboratories Limited | 1.05 Billion INR | -2156.032% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | -122.961% |
| Solara Active Pharma Sciences Limited | 14.14 Billion INR | -68.8% |
| Themis Medicare Limited | 1.88 Billion INR | -1164.876% |
| Hikal Limited | 12.99 Billion INR | -83.723% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 70.902% |
| Sequent Scientific Limited | 8.27 Billion INR | -188.542% |
| Novartis India Limited | 1.8 Billion INR | -1225.56% |
| Wockhardt Limited | 39.87 Billion INR | 40.119% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 61.036% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -8166.88% |
| Neuland Laboratories Limited | 5.49 Billion INR | -334.198% |
| Morepen Laboratories Limited | 4.45 Billion INR | -435.332% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -3607.92% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -1108.042% |